Oslo, Norway

Gunnar Kvalheim

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 169(Granted Patents)


Company Filing History:


Years Active: 1990-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gunnar Kvalheim

Introduction

Gunnar Kvalheim is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 6 patents to his name, Kvalheim's work focuses on developing innovative solutions that have the potential to transform medical practices.

Latest Patents

Kvalheim's latest patents include groundbreaking inventions such as specific binding molecules for hTERT. This invention provides a nucleic acid molecule that encodes a specific binding molecule capable of binding an hTERT peptide when presented by a Class II Major Histocompatibility Complex (MHC). The specific binding molecule comprises a first polypeptide with a variable region of an α-chain and a second polypeptide with a variable region of a β-chain of a T-cell receptor (TCR). This invention has significant utility in cancer treatment.

Another notable patent is related to universal killer T-cells. This invention involves modified natural killer (NK) cells that are non-immunogenic, allowing them to be administered to any recipient without rejection by the host immune system. These modified NK cells can express CD3 and a T-cell Receptor (TcR), enabling them to show antigen-specific cytotoxicity towards target cells. This innovation holds promise for personalized medicine, especially in oncology.

Career Highlights

Throughout his career, Kvalheim has worked with prominent organizations such as Abbott Laboratories Corporation and Oslo University Hospital. His experience in these institutions has contributed to his expertise in the field of biotechnology and cancer research.

Collaborations

Kvalheim has collaborated with notable individuals in his field, including Sébastien Wälchli and Gustav Gaudernack. These collaborations have further enhanced his research and development efforts.

Conclusion

Gunnar Kvalheim's innovative contributions to biotechnology and cancer treatment demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of cancer and the potential for personalized medicine. Kvalheim's work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…